Artiva Biotherapeutics, Inc. 4 filing

Filed 2026-02-18 · Report date 2026-02-15 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001193125-26-057669
Form type: 4
CIK: 0001817241
Primary document: https://www.sec.gov/Archives/edgar/data/1817241/000119312526057669/xslF345X05/ownership.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Artiva Biotherapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change